Kir Kahlon from Scorpion Capital makes the case that Twist Bioscience (TWST) is the latest in a long line of synthetic biology stock scams. Similar to their previous short reports on Ginkgo Bioworks and Berkeley Lights, Scorpion believes the company is promoting an absurd and fatally-flawed technology, combined with a camouflaged pricing, accounting, and capital raising scheme that is reminiscent of a Ponzi. Scorpion believes that Twist’s accounting shenanigans are Worldcom-esque, where the CEO, CFO, and numerous accounting staff went to prison.
Recent Comments